Prescription drug · NDA
Isolyte S pH 7.4 NDC 0264-7707
Sodium chloride .53 g/100mL + 6 more ingredients · Injection, Solution · Intravenous · B. Braun Medical Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0264-7707-00 | 0026477070000264770700 | 12 CONTAINER in 1 CASE (0264-7707-00) / 1000 mL in 1 CONTAINERMarketed from Sep 29, 1989 | |
| 0264-7707-10 | 0026477071000264770710 | 24 CONTAINER in 1 CASE (0264-7707-10) / 500 mL in 1 CONTAINERMarketed from Sep 29, 1989 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Isolyte S pH 7.4
- Generic name (nonproprietary)
- sodium chloride, sodium gluconate, sodium acetate, potassium chloride, magnesium chloride, sodium phosphate, dibasic, and potassium phosphate
- Active ingredients
- Sodium chloride — .53 g/100mLSodium gluconate — .5 g/100mLSodium acetate — .37 g/100mLPotassium chloride — .037 g/100mLMagnesium chloride — .03 g/100mLSodium phosphate, Dibasic — .012 g/100mLPotassium phosphate, Monobasic — .00082 g/100mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Labeler
- B. Braun Medical Inc.NDC labeler code 0264
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 019696
- Marketing start
- Listing expires
- Other FDA classes
- Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
- Identifiers
- Product ID 0264-7707_88c0041b-2b08-4ca1-b733-60f8b5723892SPL ID 88c0041b-2b08-4ca1-b733-60f8b5723892SPL set ID 150437b6-320e-4c69-a434-2a26a1f0b2e4RxCUI 800925, 800928UNII 451W47IQ8X, R6Q3791S76, 4550K0SC9B, 660YQ98I10, 02F3473H9O, GR686LBA74, 4J9FJ0HL51
- Pharmacologic class
- Calculi Dissolution Agent; Osmotic Laxative; Potassium Salt
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400264770700followed by a unit qualifier and the quantityPackage 00264-7707-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE This solution is indicated for use in adults as a source of electrolytes and water for hydration, and as an alkalinizing agent.
Excerpt only. Read the full label for complete information.
About NDC 0264-7707
- What is NDC 0264-7707?
- 0264-7707 is the product NDC for Isolyte S pH 7.4, Sodium chloride .53 g/100mL + 6 more ingredients injection, solution, listed with the FDA by B. Braun Medical Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Isolyte S pH 7.4 (SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, and POTASSIUM PHOSPHATE).
- What is the active ingredient?
- Sodium chloride, Sodium gluconate, Sodium acetate, Potassium chloride, Magnesium chloride, Sodium phosphate, Dibasic, Potassium phosphate, Monobasic.
- Who is the labeler?
- B. Braun Medical Inc., NDC labeler code 0264. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Isolyte S pH 7.4?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.